Literature DB >> 15782319

Failure of new antifungals to control Candida thrombophlebitis.

Mathieu Gazon, Marc O Robert, Serge Duperret, Patricia Branche, Jean P Viale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15782319     DOI： 10.1007/s00134-005-2591-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Guidelines for treatment of candidiasis.

Authors:  Peter G Pappas; John H Rex; Jack D Sobel; Scott G Filler; William E Dismukes; Thomas J Walsh; John E Edwards
Journal:  Clin Infect Dis       Date:  2003-12-19       Impact factor: 9.079

2.  Surgical management of Candida suppurative thrombophlebitis of superior vena cava after central venous catheterization.

Authors:  E Garcia; I Granier; A Geissler; M D Boespflug; P E Magnan; J Durand-Gasselin
Journal:  Intensive Care Med       Date:  1997-09       Impact factor: 17.440

3.  Massive septic thrombus formation on a superior vena cava indwelling catheter following Torulopsis (Candida) glabrata fungemia.

Authors:  Monica T Gressianu; Vivek N Dhruva; Rohit R Arora; Sanjeev Patel; Santos Lopez; Ayad K Jihayel; Muhamed Saric
Journal:  Intensive Care Med       Date:  2001-12-18       Impact factor: 17.440

4.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 5.  Management of candidal thrombophlebitis of the central veins: case report and review.

Authors:  D Benoit; J Decruyenaere; K Vandewoude; C Roosens; E Hoste; J Poelaert; F Vermassen; F Colardyn
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

6.  Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.

Authors:  M J Jiménez-Expósito; G Torres; A Baraldés; N Benito; F Marco; J C Paré; A Moreno; X Claramonte; C A Mestres; M Almela; C García de la María; N Pérez; W A Schell; G R Corey; J Perfect; M T Jiménez de Anta; J M Gatell; J M Miró
Journal:  Clin Infect Dis       Date:  2004-09-08       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.